Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ITRM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Iterum Therapeutics Plc stock downgraded after the last trading session.
(Updated on May 10, 2024)

Sell candidate since May 10, 2024 PDF

The Iterum Therapeutics Plc stock price fell by -3.73% on the last day (Friday, 10th May 2024) from $1.61 to $1.55. During the last trading day the stock fluctuated 6.67% from a day low at $1.50 to a day high of $1.60. The price has fallen in 6 of the last 10 days and is down by -7.19% for this period. Volume has increased on the last day by 50 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 108 thousand shares were bought and sold for approximately $166.63 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.02% during the next 3 months and, with a 90% probability hold a price between $1.58 and $2.19 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ITRM Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Iterum Therapeutics Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.58 and $1.58. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 26, 2024, and so far it has fallen -7.19%. Further fall is indicated until a new bottom pivot has been found. Iterum Therapeutics Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Iterum Therapeutics Plc stock

Iterum Therapeutics Plc finds support from accumulated volume at $1.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.100 between high and low, or 6.67%. For the last week, the stock has had daily average volatility of 5.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ITRM) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Iterum Therapeutics Plc to open at $1.55, and during the day (based on 14 day Average True Range), to move between $1.44 and $1.66, which gives a possible trading interval of +/-$0.112 (+/-7.22%) up or down from last closing price. If Iterum Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 14.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.54 (0.65%) than the resistance at $1.58 (1.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Iterum Therapeutics Plc will release earnings BMO on Monday, May 13, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.570. We will update the financials statements for Iterum Therapeutics Plc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.43% in the first trading day after earnings release.

Is Iterum Therapeutics Plc stock A Buy?

The Iterum Therapeutics Plc stock holds several negative signals and despite the positive trend, we believe Iterum Therapeutics Plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.401 Sell Candidate Downgraded

Predicted Opening Price for Iterum Therapeutics Plc of Monday, May 13, 2024

Fair opening price May 13, 2024 Current price
$1.55 ( 0%) $1.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ITRM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.65 6.45 %
R2 1.61 3.99 %
R1 1.59 2.46 %
Current price: 1.55
Support S1 1.51 -2.46 %
S2 1.49 -3.99 %
S3 1.45 -6.45 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.87 20.65 %
R2 1.59 2.58 %
R1 1.58 1.94 %
Current price 1.55
Support S1 1.54 -0.645%
S2 1.49 -3.87%
S3 1.44 -7.10%

FAQ

What is the symbol for Iterum Therapeutics Plc Stock and on which exchange is it traded?
The symbol for Iterum Therapeutics Plc is ITRM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Iterum Therapeutics Plc Stock?
The Iterum Therapeutics Plc stock holds several negative signals and despite the positive trend, we believe Iterum Therapeutics Plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Iterum Therapeutics Plc Stock?
Iterum Therapeutics Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Iterum Therapeutics Plc Stock.

What's the current price of Iterum Therapeutics Plc Stock?
As of the end of day on the May 10, 2024, the price of an Iterum Therapeutics Plc (ITRM) share was $1.55.

What is the 52-week high and low for Iterum Therapeutics Plc Stock?
The 52-week high for Iterum Therapeutics Plc Stock is $2.50 and the 52-week low is $0.622.

What is the market capitalization of Iterum Therapeutics Plc Stock?
As of the May 10, 2024, the market capitalization of Iterum Therapeutics Plc is 26.653M.

When is the next earnings date for Iterum Therapeutics Plc?
The upcoming earnings date for Iterum Therapeutics Plc is May 13, 2024.
Click to get the best stock tips daily for free!

About Iterum Therapeutics Plc

Iterum Therapeutics Plc Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company ... ITRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT